Literature DB >> 21427658

The importance of quality-of-life assessment in the management of patients with multiple sclerosis. Recommendations from the Middle East MS Advisory Group.

Abdelrahman M Al-Tahan1, Mohammed A Al-Jumah, Saeed M Bohlega, Suhail N Al-Shammari, Isa A Al-Sharoqi, Maurice P Dahdaleh, Hassan M Hosny, Bassem I Yamout.   

Abstract

Multiple sclerosis (MS) has a major negative impact on patients` health-related quality of life (QoL). A group of MS experts in the Middle East met to develop recommendations for the routine assessment of QoL in patients with MS. The group recommended that patients need to be assessed once a year using the multiple sclerosis international QoL questionnaire (MusiQoL), which is available in Arabic. Assessments should be made when patients are relapse-free to avoid confounding factors. At other clinic visits, patients` QoL should also be monitored, alongside their physical assessment, using open and structured questions on disease features that are likely to affect their QoL. This approach should allow long-term monitoring of key features of MS that are important to patients` well being, and aid decision-making regarding their management, including the use of disease-modifying drugs.

Entities:  

Mesh:

Year:  2011        PMID: 21427658

Source DB:  PubMed          Journal:  Neurosciences (Riyadh)        ISSN: 1319-6138            Impact factor:   0.906


  5 in total

1.  Development of a cross-cultural item bank for measuring quality of life related to mental health in multiple sclerosis patients.

Authors:  Pierre Michel; Pascal Auquier; Karine Baumstarck; Jean Pelletier; Anderson Loundou; Badih Ghattas; Laurent Boyer
Journal:  Qual Life Res       Date:  2015-02-25       Impact factor: 4.147

2.  Fatigue, Sleep Quality, and Disability in Relation to Quality of Life in Multiple Sclerosis.

Authors:  Fatemeh Moghaddam Tabrizi; Moloud Radfar
Journal:  Int J MS Care       Date:  2015 Nov-Dec

3.  Effectiveness, safety and health-related quality of life of multiple sclerosis patients treated with fingolimod: results from a 12-month, real-world, observational PERFORMS study in the Middle East.

Authors:  Anat Achiron; Hany Aref; Jihad Inshasi; Mohamad Harb; Raed Alroughani; Mahendra Bijarnia; Kathryn Cooke; Ozgur Yuksel
Journal:  BMC Neurol       Date:  2017-08-07       Impact factor: 2.474

4.  Quality of life among multiple sclerosis patients in Saudi Arabia.

Authors:  Hussein A Algahtani; Bader H Shirah; Faris A Alzahrani; Hind A Abobaker; Nebras A Alghanaim; Juan S Manlangit
Journal:  Neurosciences (Riyadh)       Date:  2017-10       Impact factor: 0.906

5.  Factors affecting MS patients' health-related quality of life and measurement challenges in Lebanon and the MENA region.

Authors:  Natali Farran; Batoul R Safieddine; Mariam Bayram; Tracy Abi Hanna; Joelle Massouh; Mona AlKhawaja; Hani Tamim; Hala Darwish
Journal:  Mult Scler J Exp Transl Clin       Date:  2020-01-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.